Rafferty Asset Management
WST icon

Rafferty Asset Management’s West Pharmaceutical WST Stock Holding History

Rafferty Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
7,776
+2,220
+40% +$679K 0.01% 562
2026
Q1 		$1.39M Sell
5,556
-2,190
-28% -$545K 0.01% 689
2025
Q4 		$2.13M Sell
7,746
-228
-3% -$62.4K 0.01% 634
2025
Q3 		$2.09M Buy
7,974
+387
+5% +$94.1K 0.01% 638
2025
Q2 		$1.66M Buy
7,587
+882
+13% +$189K 0.01% 652
2025
Q1 		$1.5M Sell
6,705
-1,513
-18% -$417K 0.01% 654
2024
Q4 		$2.69M Buy
8,218
+860
+12% +$271K 0.01% 560
2024
Q3 		$2.21M Sell
7,358
-572
-7% -$175K 0.01% 608
2024
Q2 		$2.61M Buy
7,930
+292
+4% +$103K 0.01% 570
2024
Q1 		$3.02M Buy
7,638
+112
+1% +$41.4K 0.01% 583
2023
Q4 		$2.65M Sell
7,526
-179
-2% -$63.3K 0.01% 596
2023
Q3 		$2.89M Buy
7,705
+510
+7% +$197K 0.02% 508
2023
Q2 		$2.75M Buy
7,195
+578
+9% +$206K 0.02% 556
2023
Q1 		$2.29M Buy
6,617
+263
+4% +$76.8K 0.02% 568
2022
Q4 		$1.5M Buy
6,354
+2,394
+60% +$567K 0.01% 656
2022
Q3 		$974K Buy
3,960
+2,163
+120% +$659K 0.01% 689
2022
Q2 		$543K Sell
1,797
-467
-21% -$152K 0.01% 787
2022
Q1 		$930K Sell
2,264
-225
-9% -$88.1K 0.01% 795
2021
Q4 		$1.17M Buy
2,489
+130
+6% +$56K 0.01% 807
2021
Q3 		$1M Buy
2,359
+637
+37% +$269K 0.01% 822
2021
Q2 		$618K Buy
1,722
+144
+9% +$47.6K ﹤0.01% 1028
2021
Q1 		$445K Buy
1,578
+115
+8% +$32.9K ﹤0.01% 987
2020
Q4 		$414K Sell
1,463
-86
-6% -$24.1K ﹤0.01% 729
2020
Q3 		$426K Sell
1,549
-5,057
-77% -$1.34M 0.01% 732
2020
Q2 		$1.5M Buy
+6,606
New +$1.3M 0.02% 431

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Rafferty Asset Management's WST Position: Q2 2026 in Review

Rafferty Asset Management increased its West Pharmaceutical (WST) stake by 40% in Q2 2026, buying an estimated $679K and bringing the position to 7,776 shares worth $2.79M. The position accounts for 0.01% of the portfolio, ranked #562.

Rafferty Asset Management first reported a position in WST in Q2 2020 and has held it in 25 quarters since. The position peaked at $3.02M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Rafferty Asset Management held 7,776 shares of West Pharmaceutical worth $2.79M as of Q2 2026.
  • Rafferty Asset Management bought 2,220 West Pharmaceutical shares in Q2 2026, an estimated $679K.
  • West Pharmaceutical made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #562 holding.
  • Rafferty Asset Management first reported a position in West Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
  • Rafferty Asset Management's West Pharmaceutical position peaked at $3.02M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.